Can I give doxycycline 200 mg intravenously once daily?

Doxycycline 200 mg IV once daily: Can I give it?

• Yes—200 mg IV once daily is acceptable for adults when IV doxycycline is indicated, with 200 mg on day 1 and then 100–200 mg/day based on severity; if choosing 200 mg/day, administer as a single daily infusion and switch to oral as soon as possible 1.

How to dose (prioritizing morbidity, mortality, and QOL)

• Adults (IV):
  • Day 1: 200 mg in 1–2 infusions.
  • Maintenance: 100–200 mg/day; for severe infections, 200 mg/day is appropriate as one daily infusion (i.e., 200 mg IV OD) 1.
• Infusion details:
  • Avoid rapid administration; infuse 100 mg over at least 1 hour; typical total daily infusion time 1–4 hours depending on dose 1.
  • Minimize thrombophlebitis; ensure proper dilution and venous access 1.
• Switch to oral promptly; IV is for when oral is not feasible. Oral bioavailability is high and outcomes are similar, improving QOL and reducing line-related harms 1.

Indication-specific notes (select high-impact scenarios)

• Pelvic inflammatory disease (parenteral regimens): doxycycline is 100 mg q12h (IV or PO) as part of combination therapy; not OD in this context 2.
• Anthrax post-exposure: 100 mg IV/PO q12h for 60 days; not OD, due to mortality prevention goals 3, 1.
• Tularemia: CDC 2025 recommends 200 mg loading, then 100 mg q12h IV/PO for 14–21 days; not OD, to reduce relapse and complications 4.
• Lyme disease: early disease uses oral regimens; IV doxycycline is rarely needed; when IV used for intolerance, total daily dose 200–400 mg/day in 2 divided doses per older IDSA table; modern guidance favors oral where possible to avoid IV risks 5, 6. For neuroborreliosis, ceftriaxone preferred IV agent 5.

Practical algorithm

• If IV route needed and the condition allows once-daily doxy (e.g., general severe infections where doxy is appropriate and no disease-specific need for q12h):
  • Use 200 mg IV once daily.
  • Reassess daily; transition to oral at first opportunity to reduce catheter complications and improve QOL 1.
• If the disease requires q12h dosing to optimize outcomes (anthrax PEP, tularemia, PID combo therapy):
  • Do not use OD; use 100 mg IV q12h (with appropriate companion drugs when indicated) to reduce morbidity/mortality 3, 4, 2.

Common pitfalls and how to avoid them

• Giving OD when guideline mandates q12h for high-risk infections (anthrax, tularemia, PID): follow q12h to prevent failure/relapse 3, 4, 2.
• Rapid infusion causing phlebitis: infuse ≥1 hour per 100 mg and ensure proper dilution 1.
• Prolonged IV when oral is feasible: switch early to improve QOL and reduce line infections 1.
• Pregnancy/children <8 years: avoid tetracyclines unless benefits outweigh risks; follow disease-specific alternatives 5, 7, 8.